ProfileGDS4718 / 202577_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 71% 74% 81% 65% 72% 81% 84% 69% 67% 73% 76% 66% 81% 81% 82% 77% 71% 82% 82% 78% 73% 71% 71% 69% 73% 79% 70% 82% 70% 83% 79% 80% 59% 69% 78% 76% 75% 71% 70% 83% 68% 81% 79% 79% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.9486171
GSM549102patient 115, normal, homogenized [OPG study]7.205574
GSM549104patient 119, normal, homogenized [OPG study]8.0212881
GSM549108patient 138, normal, homogenized [OPG study]6.4756965
GSM549119patient 077, normal, homogenized [OPG study]6.9705272
GSM549133patient 032, cancer, homogenized [OPG study]8.0964281
GSM549139patient 042, cancer, homogenized [OPG study]8.3560584
GSM549099patient 107, normal, homogenized [OPG study]6.7191269
GSM549109patient 139, normal, homogenized [OPG study]6.6305167
GSM549110patient 046, normal, homogenized [OPG study]7.1345273
GSM549114patient 063, normal, homogenized [OPG study]7.4996376
GSM549122patient 082, normal, homogenized [OPG study]6.5868966
GSM549134patient 033, cancer, homogenized [OPG study]7.9563881
GSM549136patient 036, cancer, homogenized [OPG study]8.1022481
GSM549140patient 044, cancer, homogenized [OPG study]8.1513882
GSM549111patient 047, normal, homogenized [OPG study]7.5809377
GSM549113patient 057, normal, homogenized [OPG study]6.9747671
GSM549132patient 031, cancer, homogenized [OPG study]8.0456882
GSM549137patient 038, cancer, homogenized [OPG study]8.0898382
GSM549142patient 047, cancer, homogenized [OPG study]7.452578
GSM549100patient 110, normal, homogenized [OPG study]7.1001773
GSM549107patient 135, normal, homogenized [OPG study]6.92271
GSM549115patient 068, normal, homogenized [OPG study]7.0188471
GSM549116patient 072, normal, homogenized [OPG study]6.7949869
GSM549120patient 078, normal, homogenized [OPG study]7.1218773
GSM549131patient 030, cancer, homogenized [OPG study]7.8867479
GSM549118patient 074, normal, homogenized [OPG study]6.8831270
GSM549129patient 027, cancer, homogenized [OPG study]8.1001582
GSM549123patient 088, normal, homogenized [OPG study]6.8804370
GSM549124patient 006, cancer, homogenized [OPG study]8.1294783
GSM549126patient 015, cancer, homogenized [OPG study]7.789779
GSM549128patient 025, cancer, homogenized [OPG study]7.9507880
GSM549103patient 117, normal, homogenized [OPG study]6.09959
GSM549117patient 073, normal, homogenized [OPG study]6.771569
GSM549138patient 041, cancer, homogenized [OPG study]7.6798578
GSM549141patient 045, cancer, homogenized [OPG study]7.5799576
GSM549130patient 028, cancer, homogenized [OPG study]7.3099975
GSM549101patient 111, normal, homogenized [OPG study]6.9153471
GSM549105patient 128, normal, homogenized [OPG study]6.875470
GSM549106patient 134, normal, homogenized [OPG study]8.372883
GSM549112patient 048, normal, homogenized [OPG study]6.7003668
GSM549125patient 011, cancer, homogenized [OPG study]7.944481
GSM549127patient 024, cancer, homogenized [OPG study]7.8342679
GSM549135patient 035, cancer, homogenized [OPG study]7.8785479